| Detected | Trial | Change |
|---|---|---|
| 2026-06-11 | NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… |
Trial sites expanded: 37 -> 49 locations |
| 2026-06-11 | NCT07388498 A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and… |
date change Completion moved earlier: 2028-07-18 -> 2028-06-18 |
| 2026-06-11 | NCT07015242 A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line… |
Trial sites reduced: 82 -> 40 locations |
| 2026-06-10 | NCT05254743 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic… |
Enrollment increased: 662 -> 737 participants |
| 2026-06-10 | NCT05254743 A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic… |
date change Primary completion pushed: 2025-06-10 -> 2027-10 |
| 2026-06-06 | NCT01804686 A Long-term Extension Study of PCI-32765 (Ibrutinib) |
date change Completion pushed: 2027-08-31 -> 2029-12-31 |
| 2026-06-06 | NCT05639647 Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for… |
date change Primary completion pushed: 2026-08-17 -> 2027-03-31 |
| 2026-06-06 | NCT05639647 Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for… |
date change Completion pushed: 2026-08-17 -> 2027-03-31 |
| 2026-06-06 | NCT07412470 A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults… |
Trial sites expanded: 16 -> 23 locations |
| 2026-06-05 | NCT06872333 Allo HSCT for High Risk Hemoglobinopathies |
Trial arms changed: 4 -> 5 |
| 2026-06-05 | NCT06536049 Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell… |
date change Primary completion pushed: 2026-12-31 -> 2027-08-31 |
| 2026-06-05 | NCT06536049 Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell… |
date change Completion moved earlier: 2028-12-31 -> 2027-10-31 |
| 2026-06-05 | NCT03960840 Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL |
date change Completion pushed: 2027-06-30 -> 2028-05-31 |
| 2026-06-03 | NCT05663866 Premedication to Reduce Amivantamab Associated Infusion Related Reactions |
date change Completion pushed: 2026-07-30 -> 2027-03-31 |
| 2026-06-02 | NCT04739813 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With… |
overall status: "Recruiting" → "Active Not Recruiting" |
| 2026-06-02 | NCT04739813 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With… |
Enrollment reduced: 55 -> 34 participants |
| 2026-06-02 | NCT04739813 Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With… |
date change Primary completion moved earlier: 2026-06-18 -> 2026-05-07 |
| 2026-06-02 | NCT04628767 Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients… |
Enrollment reduced: 249 -> 131 participants |
| 2026-05-30 | NCT07280156 A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused… |
Trial sites expanded: 18 -> 27 locations |
| 2026-05-29 | NCT07280156 A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused… |
Trial sites expanded: 1 -> 18 locations |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07643038 Treatment Strategy for Patients With RA-ILD | Phase 4 | Not Yet Recruiting |
| 2026-06-11 | NCT07643103 Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07634536 Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell… | Phase 2 | Not Yet Recruiting |
| 2026-06-09 | NCT07636564 Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute… | Phase 2 | Not Yet Recruiting |
| 2026-06-04 | NCT07627893 Complementary Herbal Approach to Rheumatoid Management Study (CHARMS) | Phase 2/3 | Not Yet Recruiting |
| 2026-06-03 | NCT07623200 A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… | Phase 3 | Not Yet Recruiting |
| 2026-06-03 | NCT07624903 Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy | Phase 2 | Not Yet Recruiting |
| 2026-06-02 | NCT07619898 PHOENIX-ECP- Extracorporeal Photopheresis for Immune-related Colitis and/or Hepatitis in… | Phase 2 | Not Yet Recruiting |
| 2026-05-26 | NCT07605364 Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual… | Phase 2/3 | Not Yet Recruiting |
| 2026-05-22 | NCT07603440 Intravenous Thrombolysis With Tenecteplase Plus Thrombectomy Versus Thrombectomy Alone In… | Phase 3 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07381556 | Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care… | Alopecia Areata(AA) | Recruiting |
| NCT07486843 | Preventing Structural Damage in Early Psoriatic Arthritis | Psoriatic Arthritis (PsA) | Recruiting |
| NCT06289673 | Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT07432815 | Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined… | Depression | Recruiting |
| NCT04877522 | Asciminib Roll-over Study | Chronic Myelogenous Leukemia | Recruiting |
| NCT02081755 | Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer | Carcinoma, Hepatocellular | Enrolling by Invitation |
| NCT07406204 | Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA) | Alopecia Areata | Not Yet Recruiting |
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in… | Kidney Transplantation | Active, Not Recruiting |
| NCT07477691 | Immune Modulation During Palynziq® Treatment in Adults (IMPALA) | Phenylketonuria | Not Yet Recruiting |
| NCT06578728 | Local Methotrexate Injections for the Treatment of Nail Psoriasis | Nail Psoriasis | Active, Not Recruiting |
| NCT07570433 | HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial | CMV Infection | Not Yet Recruiting |
| NCT07432386 | Methotrexate Versus Apremilast for Pruritus in Psoriasis | Psoriasis | Not Yet Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| NCT07643038 | Treatment Strategy for Patients With RA-ILD | Rheumatoid Arthritis Associated Interstitial Lung Disease | Not Yet Recruiting |
| Phase 3 | |||
| NCT04877288 | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney… | Renal Allograft Recipients | Recruiting |
| NCT07377578 | A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With… | Mantle Cell Lymphoma | Recruiting |
| NCT03593759 | Cardiac Sarcoidosis Randomized Trial | Cardiac Sarcoidosis | Recruiting |
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04293562 | A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for… | Acute Myeloid Leukemia | Recruiting |
| NCT04307576 | A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia | Leukemia, Acute Lymphoblastic | Recruiting |
| NCT04043494 | International Cooperative Treatment Protocol for Children and Adolescents With… | Lymphoblastic Lymphoma, Childhood | Recruiting |
| NCT06615050 | A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant… | Graft-versus-host Disease (GVHD) | Recruiting |
| NCT06136559 | A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib… | Chronic Lymphocytic Leukemia | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT01804686 | A Long-term Extension Study of PCI-32765 (Ibrutinib) | Chronic Lymphocytic Leukemia | Recruiting |